ARTICLE | Company News

Adaptive Biotechnologies, Argos deal

June 27, 2016 7:00 AM UTC

The companies partnered to study immune responses induced by Argos’ AGS-003 and AGS-004 immunotherapies. Adaptive will use its immunoSEQ platform, a high throughput T and B cell receptor sequencing technology, to characterize immune profiles from patient samples. ...